| Literature DB >> 35059112 |
María-Jesús Pérez-Pérez1, Juan-Carlos Saiz2, Eva-María Priego1, Miguel A Martín-Acebes2.
Abstract
The COVID pandemic has evidenced how vulnerable we are to emerging infectious diseases and how short our current armamentarium is. Flavivirus, single stranded RNA viruses transmitted by arthropods, are considered a global health challenge. No drugs to treat these infections have been approved. In this Viewpoint, we analyze the advantages and disadvantages of two different, but probably also complementary, therapeutic approaches: virus-targeting antivirals and host-targeting drugs.Entities:
Year: 2021 PMID: 35059112 PMCID: PMC8762743 DOI: 10.1021/acsmedchemlett.1c00617
Source DB: PubMed Journal: ACS Med Chem Lett ISSN: 1948-5875 Impact factor: 4.345